Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events: A Joint Statement by the AGS and National Lipid Association

All sessions are listed in Central Time (CT). 

Symposia

  • Date:
  • Time: -
  • Track: Clinical Practice
  • Location: Grand Ballroom
  • CME/CE: 1.0
  • Options: Also available on-demand

Co-Moderators: Ariel Green, MD & Joseph Saseen, PharmD, BCPS, BCACP

This session will present key findings from the joint statement related to the assessment of Atherosclerotic Cardiovascular Disease (ASCVD) risk in adults over age 75 years and the evidence for LDL-C lowering in this population. Learning Objectives: (1) discuss limitations of evidence, alternative risk calculators, and recommendations for older adults incorporating comorbidities, functional status, and cognitive status; (2) review evidence for adverse effects of statin therapies in this population; (3) describe evidence for deprescribing.

AGS & NLA's Recommendations to Manage Hypercholesterolemia in Older Adults without ASCVD
Joseph J. Saseen, PharmD, BCPS, BCACP

Balancing Risks and Benefits and Considering Deprescribing in Older Adults; Applying the Recommendations to Patients
Ariel Green, MD